Judge Asks GSK To Tweak Details In $10.4M Paxil Settlement

Law360, Los Angeles (April 25, 2012, 9:52 PM EDT) -- GlaxoSmithKline Inc.’s proposal to pay up to $10.4 million to resolve allegations that it misled California consumers about the risks of antidepressant Paxil will need revisions to determine how class members will prove they’re eligible for payments, a California judge told the drugmaker Wednesday.

Los Angeles Superior Court Judge Elihu M. Berle ordered attorneys for GSK and lead plaintiff Diana Hunter to discuss alternatives to the deal’s payment provisions, which call for $8.5 million to go to class members who have documentary proof they purchased Paxil...
To view the full article, register now.